Finance

Beta
Lists
NKTX:NASDAQ
Nkarta Inc
$2.84
+0.53%
(+0.015) 1D
Jun 29, 11:58:36 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NKTX...
Open
$2.83
High
$2.94
Low
$2.80
Mkt. cap
203.55M
Avg. vol.
597.21K
Volume
222.50K
52-wk high
$3.65
52-wk low
$1.63
EPS
-$1.35
Beta
0.91
Shares outstanding
71.54M
No. of employees
108
Open
$2.83
High
$2.94
Low
$2.80
Mkt. cap
203.55M
Avg. vol.
597.21K
Volume
222.50K
52-wk high
$3.65
52-wk low
$1.63
EPS
-$1.35
Beta
0.91
Shares outstanding
71.54M
No. of employees
108
News stories
From sources across the web
About Nkarta Inc
CEO-
Employees108
Founded2015
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitenkartatx.com
Analyst ratings
Based on 6 analysts giving stock ratings to NKTX in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for NKTX in the last 3 months.
Highest
Current $2.84
$16.00 (+462.39%)
Average
$11.80 (+314.76%)
Lowest
$9.00 (+216.34%)
Analyst
Recommendation
Action
Price target
Projected
Date
Phil Nadeau
TD Cowen
Buy
Initiated
-
-
06/23/2026
Salim Syed
Mizuho Securities
Buy
Maintained
$12.00
+321.8%
06/22/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
$9.00
+216.3%
05/18/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$11.00
+286.6%
05/13/2026
Gil Blum
Needham
Buy
Reiterated
$11.00
+286.6%
05/13/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$16.00
+462.4%
05/13/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
03/26/2026
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.37 / -$0.36
-1.37%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20.78M
20.20M
25.28M
24.99M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.41M
6.30M
5.31M
5.89M
Operating expense
27.19M
26.50M
30.59M
30.88M
Total operating expenses
27.19M
26.50M
30.59M
30.88M
Operating income
-27.19M
-26.50M
-30.59M
-30.88M
Other non operating income
239.00K
1.72M
162.00K
206.00K
EBT including unusual items
-22.98M
-21.72M
-27.41M
-27.83M
EBT excluding unusual items
-22.98M
-20.92M
-27.14M
-27.83M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-22.98M
-21.72M
-27.41M
-27.83M
Net profit margin
-
-
-
-
Earnings per share
-0.31
-0.29
-0.37
-0.37
Interest and investment income
3.97M
3.85M
3.30M
2.84M
Interest expense
-
-
-
-
Net interest expenses
3.97M
3.85M
3.30M
2.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
-24.86M
-24.19M
-28.34M
-28.54M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of NKTX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer